文献速递血液净化与透析

血液透析与腹膜透析患者的出血风险比较

Bleeding risk of haemodialysis and peritoneal dialysis patients.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该前瞻性队列研究纳入荷兰1745例新发透析患者,随访3年主要出血事件。血液透析患者出血率为60.8/1000人年,腹膜透析为34.6/1000人年;校正混杂因素后,血液透析较腹膜透析出血风险增加1.5倍(95%CI 1.0-2.2)。

要点

  • 血液透析患者出血风险较腹膜透析患者增加1.5倍(95%CI 1.0-2.2)
  • 血液透析出血率为60.8/1000人年,腹膜透析为34.6/1000人年
  • 有既往出血史的血液透析患者出血风险尤其增加

核心结论

  • 在新发透析患者中,血液透析患者较腹膜透析患者出血风险增加。
  • 尤其是有既往出血史的血液透析患者出血风险更高。

研究设计与样本

  • 荷兰透析充分性合作研究(NECOSAD)前瞻性队列,纳入1745例新发透析患者,随访3年主要出血事件。
  • 其中血液透析1211例(69.4%),腹膜透析534例(30.6%)。
  • 采用时依Cox回归分析计算血液透析对比腹膜透析的风险比及95%CI。

主要发现

  • 血液透析患者出血率为60.8/1000人年,腹膜透析患者为34.6/1000人年。
  • 校正年龄、性别、原发肾病、既往出血、心血管疾病、抗血小板药、维生素K拮抗剂、促红细胞生成素、高血压、残余肾小球滤过率、血红蛋白和 albumin 水平后,血液透析较腹膜透析出血风险增加1.5倍(95%CI 1.0-2.2)。
  • 有既往出血史的血液透析患者出血风险增加。

临床怎么用

  • 临床选择透析方式时,可将出血风险差异纳入考量,尤其对已有出血史的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dialysis patients have an increased bleeding risk as compared with the general population. However, there is limited information whether bleeding risks are different for patients treated with haemodialysis (HD) or peritoneal dialysis (PD). From a clinical point of view, this information could influence therapy choice. Therefore the aim of this study was to investigate the association between dialysis modality and bleeding risk. METHODS: Incident dialysis patients from the Netherlands Cooperative Study on the Adequacy of Dialysis were prospectively followed for major bleeding events over 3 years. Hazard ratios with 95% confidence intervals (CIs) were calculated for HD compared with PD using a time-dependent Cox regression analysis, with updates on dialysis modality. RESULTS: In total, 1745 patients started dialysis, of whom 1211 (69.4%) received HD and 534 (30.6%) PD. The bleeding rate was 60.8/1000 person-years for HD patients and 34.6/1000 person-years for PD patients. The time-dependent Cox regression analysis showed that after adjustment for age, sex, primary kidney disease, prior bleeding, cardiovascular disease, antiplatelet drug use, vitamin K antagonist use, erythropoietin use, arterial hypertension, residual glomerular filtratin rate, haemoglobin and albumin levels, bleeding risk for HD patients compared with PD increased 1.5-fold (95% CI 1.0-2.2). CONCLUSIONS: In this large prospective cohort of incident dialysis patients, HD patients had an increased bleeding risk compared with PD patients. In particular, HD patients with a history of prior bleeding had an increased bleeding risk.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. van Eck van der Sluijs A, Abrahams AC, Rookmaaker MB, et al. Bleeding risk of haemodialysis and peritoneal dialysis patients. Nephrol Dial Transplant. 2021. PMID: 33130878. doi:10.1093/ndt/gfaa216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。